Copper, gold and silver compounds as potential new anti-tumor metallodrugs (Q37855898)

24 August 2017

1 reference

title

Copper, gold and silver compounds as potential new anti-tumor metallodrugs (English)

1 reference

24 August 2017

Yaw Kai Yan

2

0 references

author name string

Shiow Jin Tan

series ordinal

1

1 reference

24 August 2017

Peter Peng Foo Lee

series ordinal

3

1 reference

24 August 2017

Kok Hwa Lim

series ordinal

4

1 reference

24 August 2017

publication date

1 October 2010

1 reference

Future Medicinal Chemistry

24 August 2017

published in

1 reference

24 August 2017

volume

2

1 reference

24 August 2017

issue

10

1 reference

24 August 2017

page(s)

1591-1608

1 reference

Platinum Compounds: a New Class of Potent Antitumour Agents

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

The Discovery and Development of Cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Cisplatin is a DNA-damaging antitumour compound triggering multifactorial biochemical responses in cancer cells: importance of apoptotic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Historical review of the use of silver in the treatment of burns. I. Early uses

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Gold-based therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

New trends for metal complexes with anticancer activity

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Copper complexes as anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Copper compounds in anticancer strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

New metal complexes as potential therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Anticancer and antimicrobial metallopharmaceutical agents based on palladium, gold, and silver N-heterocyclic carbene complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Gold derivatives for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Co-treatment with copper compounds dramatically decreases toxicities observed with cisplatin cancer therapy and the anticancer efficacy of some copper chelates supports the conclusion that copper chelate therapy may be markedly more effective and le

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Organic copper complexes as a new class of proteasome inhibitors and apoptosis inducers in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Pyrrolidine dithiocarbamate-zinc(II) and -copper(II) complexes induce apoptosis in tumor cells by inhibiting the proteasomal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Copper in medicine: homeostasis, chelation therapy and antitumor drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Free radicals, metals and antioxidants in oxidative stress-induced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Direct binding of Cu(II)-complexes of oxicam NSAIDs with DNA backbone.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Copper(II) complexes of salicylaldehyde hydrazones: synthesis, structure, and DNA interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Anti-oxidant, in vitro, in vivo anti-inflammatory activity and antiproliferative activity of mefenamic acid and its metal complexes with manganese(II), cobalt(II), nickel(II), copper(II) and zinc(II).

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Anti-inflammatory, antiproliferative, and radical-scavenging activities of tolfenamic acid and its metal complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Prostaglandins and cancer: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Modulation of the biological properties of aspirin by formation of a bioorganometallic derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Synthesis and characterization of dinuclear macrocyclic cobalt(II), copper(II) and zinc(II) complexes derived from 2,2,2('),2(')-S,S[bis(bis-N,N-2-thiobenzimidazolyloxalato-1,2-ethane)]: DNA binding and cleavage studies

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Synthesis and characterization of a new macrocyclic copper(II) complex with an N-glycosidic pendant arm: in vitro cytotoxicity and binding studies with calf-thymus DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Synthesis, crystal structure, DNA binding and photo-induced DNA cleavage activity of (S-methyl-L-cysteine)copper(II) complexes of heterocyclic bases.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Potential for proteasome inhibition in the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

The proteasome: a novel target for cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Abnormally high expression of proteasomes in human leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Bax degradation by the ubiquitin/proteasome-dependent pathway: involvement in tumor survival and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Copper-adenine complex, a compound, with multi-biochemical targets and potential anti-cancer effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Mechanism of irreversible inactivation of phosphomannose isomerases by silver ions and flamazine.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Ag(I)-N bond-containing compound showing wide spectra in effective antimicrobial activities: polymeric silver(I) imidazolate

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Synthesis and structure of a water-soluble hexanuclear silver(I) nicotinate cluster comprised of a "cyclohexane-chair"-type of framework, showing effective antibacterial and antifungal activities: use of "sparse matrix" techniques for growing crysta

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Synthesis and characterization of water-soluble silver(I) complexes with L-histidine (H2his) and (S)-(-)-2-pyrrolidone-5-carboxylic acid (H2pyrrld) showing a wide spectrum of effective antibacterial and antifungal activities. Crystal structures of c

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

In vitro anti-tumour and cyto-selective effects of coumarin-3-carboxylic acid and three of its hydroxylated derivatives, along with their silver-based complexes, using human epithelial carcinoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Role of cell cycle events and apoptosis in mediating the anti-cancer activity of a silver(I) complex of 4-hydroxy-3-nitro-coumarin-bis(phenanthroline) in human malignant cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

New transition metal ion complexes with benzimidazole-5-carboxylic acid hydrazides with antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Mitochondrial permeability transition induced by dinuclear gold(I)-carbene complexes: potential new antimitochondrial antitumour agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Metal-NHC complexes: a survey of anti-cancer properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Inhibitory effects of a new oral gold compound on hela cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Inhibition of thioredoxin reductase by auranofin induces apoptosis in cisplatin-resistant human ovarian cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Gold(I) complexes determine apoptosis with limited oxidative stress in Jurkat T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Pro-apoptotic effect of aurothiomalate in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

In vitro antitumour and hepatotoxicity profiles of Au(I) and Ag(I) bidentate pyridyl phosphine complexes and relationships to cellular uptake.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Gold(I) chloride adducts of 1,3-bis(di-2-pyridylphosphino)propane: synthesis, structural studies and antitumour activity

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

A gold(I) phosphine complex selectively induces apoptosis in breast cancer cells: implications for anticancer therapeutics targeted to mitochondria.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Synthesis, structure and cytotoxicity studies of diisopropylammonium and triethylammonium salts of triphenylphosphinegold(I) sulfanylcarboxylates

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

A gold(I) phosphine complex containing a naphthalimide ligand functions as a TrxR inhibiting antiproliferative agent and angiogenesis inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Mitochondria-targeted chemotherapeutics: the rational design of gold(I) N-heterocyclic carbene complexes that are selectively toxic to cancer cells and target protein selenols in preference to thiols.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Cationic, linear Au(I) N-heterocyclic carbene complexes: synthesis, structure and anti-mitochondrial activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Synthesis, structural characterisation and anti-proliferative activity of NHC gold amino acid and peptide conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Towards the rational design of platinum(II) and gold(III) complexes as antitumour agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Gold(III) porphyrins as a new class of anticancer drugs: cytotoxicity, DNA binding and induction of apoptosis in human cervix epitheloid cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Inhibition of Akt sensitises neuroblastoma cells to gold(III) porphyrin 1a, a novel antitumour drug induced apoptosis and growth inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Gold(III) compound is a novel chemocytotoxic agent for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Gold(III) porphyrin complex is more potent than cisplatin in inhibiting growth of nasopharyngeal carcinoma in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Gold (III) porphyrin complexes induce apoptosis and cell cycle arrest and inhibit tumor growth in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Modulation of gold(III) porphyrin 1a-induced apoptosis by mitogen-activated protein kinase signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

PI3K-Akt pathway: its functions and alterations in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Antiproliferative and apoptotic effects of two new gold(III) methylsarcosinedithiocarbamate derivatives on human acute myeloid leukemia cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Synthesis, characterization, and comparative in vitro cytotoxicity studies of platinum(II), palladium(II), and gold(III) methylsarcosinedithiocarbamate complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Gold dithiocarbamate derivatives as potential antineoplastic agents: design, spectroscopic properties, and in vitro antitumor activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Gold(III) dithiocarbamate derivatives for the treatment of cancer: solution chemistry, DNA binding, and hemolytic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Gold(III)-dithiocarbamato complexes induce cancer cell death triggered by thioredoxin redox system inhibition and activation of ERK pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

A novel anticancer gold(III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26S proteasome in human breast cancer cell cultures and xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

The tumor proteasome as a novel target for gold(III) complexes: implications for breast cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Gold(III) compounds of 1,4,7-triazacyclononane showing high cytotoxicity against A-549 and HCT-116 tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

DNA binding properties of novel cytotoxic gold(III) complexes of terpyridine ligands: the impact of steric and electrostatic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Anticancer cyclometalated [Au(III)m(C(wedge)N(wedge)C)mL]n+ compounds: Synthesis and cytotoxic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Structural and solution chemistry, antiproliferative effects, and DNA and protein binding properties of a series of dinuclear gold(III) compounds with bipyridyl ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Structural characterization, solution studies, and DFT calculations on a series of binuclear gold(III) oxo complexes: relationships to biological properties

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

The molecular biology of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Copper deficiency as an anti-cancer strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Copper-induced vascular endothelial growth factor expression and wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Gene transfer of CuZn superoxide dismutase enhances the synthesis of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

The release of fibroblast growth factor-1 from melanoma cells requires copper ions and is mediated by phosphatidylinositol 3-kinase/Akt intracellular signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Copper binding affinity of S100A13, a key component of the FGF-1 nonclassical copper-dependent release complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Generalized argyria after habitual use of AgNO3.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Cysteine protects Na,K-ATPase and isolated human lymphocytes from silver toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Cytotoxicity of topical antimicrobial agents used in burn wounds in Australasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Effects of silver in isolated rat hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Nephrotic Syndrome Following Topically Applied Sulfadiazine Silver Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Toxicity of anti-rheumatic drugs in a randomized clinical trial of early rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Gold induced nephropathy in rheumatoid arthritis and HLA class II genes

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Copper chelation by D-penicillamine generates reactive oxygen species that are cytotoxic to human leukemia and breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Investigation of DNA-binding properties of organic molecules using quantitative structure-activity relationship (QSAR) models

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Cytotoxicity of salicylaldehyde benzoylhydrazone analogs and their transition metal complexes: quantitative structure-activity relationships.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Complexes of salicylaldehyde acylhydrazones: cytotoxicity, QSAR and crystal structure of the sterically hindered t-butyl dimer

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

QSAR studies of copper azamacrocycles and thiosemicarbazones: MM3 parameter development and prediction of biological properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

DNA interaction studies and evaluation of biological activity of homo- and hetero-trihalide mononuclear Cu(II) Schiff base complexes. Quantitative structure-activity relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Synthesis and cytotoxic activity of benzopyran-based platinum(II) complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Antiproliferative activity and QSAR study of copper(II) mixed chelate [Cu(N-N)(acetylacetonato)]NO3 and [Cu(N-N)(glycinato)]NO3 complexes, (Casiopeínas).

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Effect of metal coordination on the interaction of substituted phenanthroline and pyridine ligands with quadruplex DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Silver and its application as an antimicrobial agent

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

[Ag2(aca)2]n and [Ag4(aca)4(NH3)2] (acaH=9-anthracenecarboxylic acid): Synthesis, X-ray crystal structures, antimicrobial and anti-cancer activities

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

Thioredoxin reductase: A target for gold compounds acting as potential anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.234

21 January 2018

Identifiers

DOI

10.4155/FMC.10.234

1 reference

24 August 2017

1 reference